Navigation Links
QED International Associates Announces Changes to the HealthShares(TM) Cardio Devices Index (As Revised)
Date:4/4/2008

NEW YORK, April 4, 2008 /PRNewswire/ -- QED International Associates, Inc., administrator for the HealthShares(TM) Indexes, a series of 20 underlying indexes for the HealthShares(TM) Exchange-Traded Funds, today announced that effective at the opening of trading on Monday April 7, 2008, Masimo Corporation (Nasdaq: MASI) will replace Possis Medical, Inc. (Nasdaq: POSS) in the HealthShares(TM) Cardio Devices Index. Possis is being acquired by Bayer AG (NYSE: BAY).

Previously it was reported that BARCO (BAR.BR) was going to replace Possis.

Companies that are included in the HealthShares(TM) Cardio Devices Index are engaged in the manufacture, distribution and commercialization of medical devices for the treatment of cardiac, vascular, and endovascular disorders and diseases.

About QED International Associates

QED International, based in New York, is a leading financial industry consulting firm specializing in quantitative modeling and the design, development and maintenance of indexes and Exchange Traded Funds. For more information, visit the company's website at http://www.qedinternational.com


'/>"/>
SOURCE QED International Associates, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. NTMir Announces First International Research Grant for Genome Sequencing
2. Siemens Showcases Worlds First Pocket Ultrasound System at the International Conference on Emergency Medicine 2008
3. QED International Associates Announces Changes to the HealthShares(TM) Cardio Devices Index
4. Chindex International Announces the Opening of Wuxi United Family Healthcare Center
5. MINRAD International, Inc. Announces 2007 Financial Results
6. China Yingxia International, Inc. Announces Record Fourth Quarter and Year 2007 Results
7. MINRAD International, Inc. to Discuss 2007 Fourth Quarter and Full Year Financial Results on Monday, March 31, 2008
8. International Isotopes Inc. Announces Year End Financial Results
9. China Yingxia International Announces Soybean Milk Production Lines Acquisition
10. Infant formula must contain DHA omega-3 and AA omega-6, say international experts
11. The Top Ten Health Tips for International Travel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2017)... MA (PRWEB) , ... June 20, 2017 , ... Kenneth ... International AIDS Society (JIAS). , Dr. Mayer, who joined the JIAS Editorial Board ... is the founding Medical Research Director of Fenway Health and Co-Chair of ...
(Date:6/20/2017)... , ... June 20, 2017 , ... Leading dental clinicians, ... imaging technology with the VATECH PaX-i and Anatomage systems. With advanced digital images and ... they can place dental implants precisely and restore oral health for those who are ...
(Date:6/20/2017)... , ... June 20, 2017 , ... ... Clinical Innovation Catalyst program focused on finding product improvements that could reduce ... in their throats when they need help breathing or to provide medication. Sometimes, ...
(Date:6/20/2017)... (PRWEB) , ... June 20, 2017 , ... ... staffing agency, recently became re-accredited by the Joint Commission, which accredits ... Commission accreditation and certification is recognized nationwide as a symbol of quality that ...
(Date:6/20/2017)... ... 20, 2017 , ... The law firm of Momkus McCluskey Roberts LLC ... of the DuPage County Bar Association’s Board of Directors. Cassioppi officially took on the ... Drake in Oak Brook. Momkus McCluskey Roberts LLC attorney Stacey A. McCullough was also ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... -- Novavax, Inc., (Nasdaq: NVAX ) today announced that ... its RSV F protein recombinant nanoparticle vaccine candidate (RSV F ... in the journal Vaccine (the data ... conferences). The Company previously announced top line results ... RSV F Vaccine with the goal of protecting infants from ...
(Date:6/3/2017)...  Eli Lilly and Company (NYSE: ... Phase 3 MONARCH 2 study showed that abemaciclib, ... combination with fulvestrant, significantly improved progression-free survival (PFS) ... with hormone-receptor-positive (HR+), human epidermal growth factor receptor ... or progressed after endocrine therapy (median PFS, 16.4 ...
(Date:5/30/2017)... May 30, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... Global Healthcare Conference on Tuesday, June 13, 2017, in ... , Hill-Rom,s president and chief executive officer, is scheduled to ... audio webcast can be accessed at http://ir.hill-rom.com/events.cfm . A ... the live event through September 13, 2017. ...
Breaking Medicine Technology: